Afinitor Sales Data
|Rank 97||Current sales rank, all
Last updated: February 2014 (updated quarterly).
The following data shows Afinitor U.S. retail sales in Q4 2013 compared to previous quarters.
|Date Range||Sales Rank||Sales ($000)||Units (000)|
|Q4 2013||97 (1)||$180,719||0.03%||24|
|Q3 2013||96 (4)||$180,669||5.45%||24|
|Q2 2013||100 ()||$171,337||24|
* Units refer to the number of packages sold.
|September 25, 2015||New Immune-Focused Drug Shows Promise Against Advanced Kidney Cancer|
|September 26, 2011||Novartis Drug Afinitor Helps Women With Advanced Breast Cancer Live Significantly Longer Without Their Disease Progressing|
|May 6, 2011||FDA Panel Oks Novartis' Pancreatic Tumor Drug|
|November 1, 2010||Afinitor Approved for Rare Genetic Disorder|